NuVasive Announces Conference Call and Webcast of First Quarter 2022 Results

Rhea-AI Summary

NuVasive, Inc. (NASDAQ: NUVA) announced the upcoming release of its first quarter 2022 financial results on May 4, 2022, after market close. A conference call to discuss the results will follow at 4:30 p.m. ET. Interested parties can access the call via dial-in or webcast. NuVasive specializes in spine technology, offering minimally disruptive surgical solutions and generating over $1 billion in net sales across more than 50 countries. However, the company cautions that its forward-looking statements may involve risks and uncertainties affecting future performance.

Positive

• NuVasive is a leader in spine technology with over $1 billion in net sales.
• The company operates in more than 50 countries, enhancing its market presence.

Negative

• Forward-looking statements indicate potential risks and uncertainties regarding future financial performance.
• There may be inaccuracies in net sales or earnings projections due to the preliminary nature of forecasts.

SAN DIEGO, April 20, 2022 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced today the Company will release its first quarter results on Wednesday, May 4, 2022, after the close of the market.

NuVasive will hold a conference call on Wednesday, May 4, 2022, at 4:30 p.m. ET / 1:30 p.m. PT to discuss the results of its financial performance for the first quarter ended March 31, 2022. The dial-in numbers are 1-877-407-9039 for domestic callers and 1-201-689-8470 for international callers. A live webcast of the conference call and supplemental financial information of our first quarter 2022 results will be available on the Investor Relations page of our website at www.nuvasive.com. An audio replay of the call will be available until May 11, 2022. The replay dial-in numbers are 1-844-512-2921 for domestic callers and 1-412-317-6671 for international callers. Please use pin number: 13728729.  In addition, the webcast will be archived on NuVasive's website. 

About NuVasive
NuVasive, Inc. (NASDAQ: NUVA) is the leader in spine technology innovation, with a mission to transform surgery, advance care, and change lives. The Company's less-invasive, procedurally integrated surgical solutions are designed to deliver reproducible and clinically proven outcomes. The Company's comprehensive procedural portfolio includes surgical access instruments, spinal implants, fixation systems, biologics, software for surgical planning, navigation and imaging solutions, magnetically adjustable implant systems for spine and orthopedics, and intraoperative neuromonitoring technology and service offerings. With more than $1 billion in net sales, NuVasive operates in more than 50 countries serving surgeons, hospitals, and patients. For more information, please visit www.nuvasive.com.

Forward-Looking Statements
NuVasive cautions you that statements included in this news release and the associated conference call and webcast that are not a description of historical facts are forward-looking statements that involve risks, uncertainties, assumptions and other factors which, if they do not materialize or prove correct, could cause NuVasive's results to differ materially from historical results or those expressed or implied by such forward-looking statements. The potential risks and uncertainties which contribute to the uncertain nature of these statements include, but are not limited to, the risk that NuVasive's net sales or earnings projections may turn out to be inaccurate because of the preliminary nature of the forecasts; the risk of further adjustment to financial results or future financial expectations; unanticipated difficulty in selling products, generating net sales or producing expected profitability; and those other risks and uncertainties more fully described in NuVasive's news releases and periodic filings with the Securities and Exchange Commission. NuVasive's public filings with the Securities and Exchange Commission are available at www.sec.gov. NuVasive assumes no obligation to update any forward-looking statement to reflect events or circumstances arising after the date on which it was made.

View original content to download multimedia:https://www.prnewswire.com/news-releases/nuvasive-announces-conference-call-and-webcast-of-first-quarter-2022-results-301529494.html

SOURCE NuVasive, Inc.

FAQ

When will NuVasive release its first quarter 2022 financial results?

NuVasive will release its first quarter 2022 financial results on May 4, 2022, after market close.

What time is the conference call for NuVasive's first quarter results?

The conference call is scheduled for May 4, 2022, at 4:30 p.m. ET.

How can I access NuVasive's conference call?

You can access the conference call by dialing 1-877-407-9039 for domestic callers or 1-201-689-8470 for international callers.

What is NuVasive’s business focus?

NuVasive focuses on spine technology innovation and offers minimally invasive surgical solutions.

What risks are associated with NuVasive's forward-looking statements?

Risks include potential inaccuracies in net sales or earnings projections and other uncertainties that could affect future performance.